Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for prevention of shivering during cesarean section under spinal anesthesia
IRCT20240524061880N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in postanesthetic shivering (PAS) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Severe shivering and Bruslers. Started Jan 2025; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on IRCT20240524061880N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240524061880N1.